Issue: Volume V No. 11 - August 17, 1998

United Health’s Big Losses Derail Merger With Humana

CEO SUMMARY: Considered the darling of the managed care industry by investors, United Healthcare’s huge write-down makes it the latest healthcare behemoth to post an immense loss. Laboratory executives should see this as a sign that even big healthcare companies are struggling to develop fiscal stability.Medicare HMOs are believed to be one major source of …

United Health’s Big Losses Derail Merger With Humana Read More »

“Corporatized” Healthcare Encountering Big Losses

CEO SUMMARY: When the clinical laboratory industry found itself losing hundreds of millions of dollars in recent years, few people imagined that billion-dollar HMO and PPM companies would soon experience similar losses. Current trends in the managed care marketplace indicate that problems for these huge healthcare companies translate into continued downward pricing pressure for laboratory …

“Corporatized” Healthcare Encountering Big Losses Read More »

AACC Convention Exhibits Point To New Lab Trends

CEO SUMMARY: This year the interesting trend at the AACC’s exhibit hall was modular laboratory automation. That’s a big change from the total laboratory automation solutions touted in past years. But watch out! The economics of this equipment have yet to be validated. It was also clear that another coming trend is the globalization of …

AACC Convention Exhibits Point To New Lab Trends Read More »

Blunt Talk From HMO Blue’s Ancillary Contracts Manager

CEO SUMMARY: By now, most clinical laboratory executives and pathologists have discovered a new fact of life: provider status with managed care organizations is a critical success factor. Without provider status, the laboratory is denied access to patients and the reimbursement associated with those patients. Here is candid information about how and why a managed …

Blunt Talk From HMO Blue’s Ancillary Contracts Manager Read More »

AccuMed, AutoCyte, Cytyc, MorphoMetrix, Neuromedical, NeoPath

Automated Cytology Update As predicted by THE DARK REPORT, the field of automated cytology has become a boiling pot, filled with controversy and change. Profits are meager. As we expected, the major issue revolves around the cost of this enhanced technology versus the measurable clinical benefits it delivers over traditional Pap smear procedures. Here’s a …

AccuMed, AutoCyte, Cytyc, MorphoMetrix, Neuromedical, NeoPath Read More »

“August 17, 1998 Intelligence: Late Breaking Lab News”

THE DARK REPORT wants to thank those companies at the American Association of Clinical Chemistry convention in Chicago who invited us to special business briefings and other functions. It was an opportunity to meet both executives and the innovative customers of these companies who are advancing the art (and science) of laboratory management. Such meetings …

“August 17, 1998 Intelligence: Late Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.